In addition, we have demonstrated a marked enhancement of anti-HCoV-HKU1 S-RBD and anti-OC43 S1 antibody titers in serum samples from convalescent COVID-19 patients, indicating an activation of cross-reactive immunological memory response to conserved β-coronavirus spike antigens. This evidence concerns the gene PSMD1 and COVID-19.